Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Edgard Quintella"'
Autor:
Marcio Costa, Edgard Quintella, Leonardo Hadid, Verônica Nasr, Maximiliano Lacoste, Alexandre Fuchs
Publikováno v:
Journal of Transcatheter Interventions. 29:1-5
The Gerbode defect is defined as an abnormal communication between the left ventricle and the right atrium, and is etiologically classified as congenital or acquired (iatrogenic or not). The typical treatment consists of surgical repair of the shunt,
Autor:
Anis Rassi, Remo H.M. Furtado, João B M C Moraes, Antonio Carlos Carvalho, Carlos E. Rochitte, Edgard Quintella, Adrian P M Korman, Hélio José Castello, Costantino R Costantini, Adriano Caixeta, MiHeart, Suzana A. Silva, Marco A Mattos, Jose C. Nicolau, Hans F. Dohmann, Ami Investigators
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Background Left ventricular ejection fraction (LVEF) is a major determinant of long-term prognosis after ST-segment elevation myocardial infarction (STEMI). STEMI patients with reduced LVEF have a poor prognosis, despite successful reperfusion and th
Autor:
C.G. Vinagre, Edgard Quintella, Andrei C. Sposito, Pedro A. Lemos, Laura Ines Ventura, Raul D. Santos, Otávio Luiz Gomes Carneiro, Raul C. Maranhão, José Antonio Franchini Ramires
Publikováno v:
Atherosclerosis. 176:397-403
The atherogenic role of a delayed intravascular catabolism of chylomicrons has been suggested by univariate analysis of case-control studies. However, it is not established whether this association is caused by a direct atherogenic effect of these li
Autor:
José Antonio Franchini Ramires, Otávio Luiz Gomes Carneiro, Pedro A. Lemos, Andrei C. Sposito, Whady Hueb, Raul C. Maranhão, M. John Chapman, Raul D. Santos, Carmen G. C. Vinagre, Edgard Quintella
Publikováno v:
Journal of the American College of Cardiology. 43(12):2225-2232
Objectives We sought to verify whether the intravascular metabolism of chylomicron-like emulsion may predict the clinical evolution of patients with coronary artery disease (CAD) undergoing secondary prevention therapy of CAD. Background Case-control